The Cell Therapy and Regenerative Medicine Program (CellReGen™) was originally established to support the Blood & Marrow Transplant Program in the early 1990’s, maintaining vital accreditations since 2000. CellReGen™ then expanded expertise in the field of Regenerative Medicine to provide a platform for researchers and biotech companies to advance manufacturing opportunities into the clinical setting. CellReGen™ invests resources to develop new ideas and products to be used for research and clinical applications.
CellReGen™ is located in a 14,000 square foot state-of-the-art facility:
- Four Independent ISO Class 7 cGMP clean-rooms
- GLP Processing Laboratories
- Viral Transduction Suite
- Segregated Research and Development Laboratory